CHM
Chimeric Therapeutics Limited
1 day chart
About CHM
Chimeric Therapeutics Limited (CHM) is an Australian clinical stage cell therapy company focused on developing and commercialising a range of cell therapies in oncology. Products under development by the group are NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies.
Buy Australian shares starting with CHM. Invest today with a CHESS-sponsored broker!
Market Capitalisation
$27M
Price-earnings ratio
-1.40
Dividend yield
0.00%
High today
$0.06
Low today
$0.06
Open price
$0.06
52-week high
$0.16
52-week low
$0.06
Announcements
CHM FAQs
How much is one share of Chimeric Therapeutics Limited?
One share of Chimeric Therapeutics Limited is valued at $0.06.
What is the ticker symbol for Chimeric Therapeutics Limited?
The ticker symbol for Chimeric Therapeutics Limited is CHM.
How do I buy CHM shares in Australia?
To buy CHM stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in CHM
What is the 52-week high for Chimeric Therapeutics Limited stock?
The Chimeric Therapeutics Limited 52-week high stock price is $0.16.
What is the 52-week low for Chimeric Therapeutics Limited stock?
The Chimeric Therapeutics Limited 52-week low stock price is $0.06.
What is the market capitalisation of Chimeric Therapeutics Limited CHM?
As of 29/03/2023 Chimeric Therapeutics Limited has a market cap of $27M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.